PharmaTher receives FDA approval goal date for ketamine
PharmaTher (PHRRF) has received an Amendment Acknowledgement Letter from the U.S. Food and Drug Administration for its New Drug Application for ...
PharmaTher receives FDA priority review for ketamine new drug application
Ketamine stock PharmaTher Holdings (CSE:PHRM) has received an amendment acknowledgement letter from the U.S. Food and Drug ...
Becker's ASC2d
FDA advances new drug application for ketamine
Specialty pharmaceutical company PharmaTher Holdings’ drug application for Ketamine has received a June 4 approval goal date, advancing approval of the drug in the U.S. PharmaTher said it is ...
Yahoo Finance1mon
PharmaTher Provides Update on FDA New Drug Application for Ketamine
TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical ...
Nasdaq1mon
PharmaTher Updates On FDA Resubmission For Ketamine Approval
(RTTNews) - PharmaTher Holdings Ltd. (PHRM), on Wednesday, provided an update on its New Drug Application or NDA for ketamine, announcing plans to resubmit the necessary information to the FDA by ...
Yahoo Finance12d
PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
Toronto, Ontario--(Newsfile Corp. - March 3, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical ...
PharmaTher Receives US FDA Approval Goal Date for Ketamine
“I am very pleased with the new FDA approval goal date of June 4, 2025 for our Ketamine drug. We are focused on solving the shortage issue of Ketamine and becoming the leading supplier of Ketamine to ...
Morningstar4d
PharmaTher Receives US FDA Approval Goal Date for Ketamine
TORONTO, March 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical ...